PrednisoneAntibodies, Monoclonal, Murine-DerivedAntigens, CD20VincristineAntibodies, MonoclonalCyclophosphamideImmunologic FactorsLymphoma, FollicularDoxorubicinAntineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeLymphoma, Large B-Cell, DiffuseLymphoma, B-CellGlucocorticoidsImmunosuppressive AgentsRemission InductionPrednisoloneLymphoma, Non-HodgkinDrug Administration ScheduleDrug Therapy, CombinationAntineoplastic AgentsProcarbazineAntirheumatic AgentsLymphoma, Mantle-CellAzathioprineMitoxantroneMechlorethamineMethotrexateVidarabineRecurrenceLeukemia, Lymphocytic, Chronic, B-CellAnemia, Hemolytic, AutoimmuneDisease-Free SurvivalB-LymphocytesMelphalanPurpura, Thrombocytopenic, IdiopathicFollow-Up StudiesChlorambucilAnti-Inflammatory AgentsWaldenstrom MacroglobulinemiaBleomycinArthritis, RheumatoidMethylprednisoloneSurvival AnalysisCombined Modality TherapyAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisNephrotic SyndromeSurvival RateMycophenolic AcidHodgkin DiseaseLymphocyte DepletionEtoposideSalvage TherapyAdrenal Cortex HormonesColor TherapyPlasmapheresisKidney TransplantationTime FactorsRetrospective StudiesThalidomideBoronic AcidsPyrazinesLymphomaGraft RejectionCladribineCyclosporinePrognosisNitrogen Mustard CompoundsDose-Response Relationship, DrugLymphoproliferative DisordersInfusions, IntravenousAdministration, OralProspective StudiesPlasma ExchangeClinical Trials as TopicDexamethasoneTransplantation, AutologousThrombocytopeniaChemotherapy-Induced Febrile NeutropeniaImmunoglobulins, IntravenousVinblastineKaplan-Meier EstimatePemphigusAsparaginaseAntibody-Dependent Cell CytotoxicityCryoglobulinemiaGlomerulonephritis, MembranousImmunotherapyChillsInfectionMultiple MyelomaCytarabineTacrolimusDouble-Blind MethodDrug Resistance, NeoplasmLupus Erythematosus, SystemicDisease ProgressionVindesineMaintenance ChemotherapyAntibodies, Monoclonal, Humanized